Evaluation of the International Prognostic Score (IPS-7) and a Simpler Prognostic Score (IPS-3) for advanced Hodgkin lymphoma in the modern era

British Journal of Haematology
Catherine S DiefenbachRanjana H Advani

Abstract

The International Prognostic Score (IPS-7) is the most commonly used risk stratification tool for advanced Hodgkin lymphoma (HL), however recent studies suggest the IPS-7 is less discriminating due to improved outcomes with contemporary therapy. We evaluated the seven variables for IPS-7 recorded at study entry for 854 patients enrolled on Eastern Cooperative Oncology Group 2496 trial. Univariate and multivariate Cox models were used to assess their prognostic ability for freedom from progression (FFP) and overall survival (OS). The IPS-7 remained prognostic however its prognostic range has narrowed. On multivariate analysis, two factors (age, stage) remained significant for FFP and three factors (age, stage, haemoglobin level) for OS. An alternative prognostic index, the IPS-3, was constructed using age, stage and haemoglobin level, which provided four distinct risk groups [FFP (P = 0·0001) and OS (P < 0·0001)]. IPS-3 outperformed the IPS-7 on risk prediction for both FFP and OS by model fit and discrimination criteria. Using reclassification calibration, 18% of IPS-7 low risk patients were re-classified as intermediate risk and 13% of IPS-7 intermediate risk patients as low risk. For patients with advanced HL, the IPS-3 may p...Continue Reading

References

Mar 2, 2005·Biometrics·Patrick J Heagerty, Yingye Zheng
Jun 9, 2005·Annals of Oncology : Official Journal of the European Society for Medical Oncology·M HutchingsA R Timothy
Jun 16, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Andreas EngertUNKNOWN German Hodgkin's Study Group
Jan 7, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoUNKNOWN HD2000 Gruppo Italiano per lo Studio dei Linfomi Trial
Aug 5, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Massimo FedericoPhilippe Solal-Céligny
Mar 12, 2010·The New England Journal of Medicine·Christian SteidlRandy D Gascoyne
Aug 18, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hans Theodor EichAndreas Engert
Sep 8, 2010·The New England Journal of Medicine·Andreas EngertVolker Diehl
Jul 22, 2011·The New England Journal of Medicine·Simonetta VivianiUNKNOWN Intergruppo Italiano Linfomi
Mar 29, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Anas YounesRobert Chen
Aug 8, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alden A MocciaLaurie H Sehn
Nov 28, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David W ScottRandy D Gascoyne
Mar 22, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Alberto BiggiSally F Barrington
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bruce D ChesonT Andrew Lister
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sally F BarringtonBruce D Cheson

❮ Previous
Next ❯

Citations

Aug 9, 2016·Seminars in Hematology·Theodoros P Vassilakopoulos, Peter W M Johnson
Aug 9, 2016·Seminars in Hematology·Paul J BröckelmannTheodoros P Vassilakopoulos
Jul 1, 2020·British Journal of Haematology·John V AsimakopoulosTheodoros P Vassilakopoulos
Jun 2, 2016·American Society of Clinical Oncology Educational Book·Ryan C Lynch, Ranjana H Advani
Dec 14, 2019·Journal of Global Oncology·Arun SeshachalamHemant Deepak Shewade
Apr 14, 2016·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Oliver W PressJonathan W Friedberg
Jan 4, 2017·Journal of the National Cancer Institute·Catherine S DiefenbachNancy L Bartlett
Dec 25, 2019·Annals of Hematology·Alessia BariUNKNOWN Fondazione Italiana Linfomi (Onlus)
Feb 9, 2021·Leukemia Research·Semra PaydasVehbi Ercolak

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.